◆英語タイトル:Parexel International Corp - Strategic SWOT Analysis Review
◆商品コード:DATA904C7727
◆発行会社(調査会社):
GlobalData
◆発行日:2018年10月
◆ページ数:48
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Parexel International Corp – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
Highlights
Parexel International Corp (Parexel) is a biopharmaceutical outsourcing service company which focuses on providing various services for managing the biopharmaceutical product lifecycle and for the development and commercialization of new medical therapies. It offers a comprehensive range of services including clinical trials management, observational studies and patient/disease registries, data management, biostatistical analysis, epidemiology, health economics/outcomes research, pharmacovigilance, medical communications, clinical pharmacology, patient recruitment, clinical supply and drug logistics, post-marketing surveillance, regulatory and product development and commercialization consulting among several others. Parexel caters its products and services to pharmaceutical, biotechnology and medical device industries worldwide. The company offers its services through a network of offices in various countries across the world. Parexel is headquartered in Waltham, Massachusetts, the US.
Parexel International Corp Key Recent Developments
Oct 09,2018: PAREXEL announces several new patient-centric innovations to address drug development challenges
Sep 17,2018: PAREXEL and Datavant partner to deliver advanced data and Real-World Evidence Analytics to enhance drug development and commercialization
Sep 17,2018: PAREXEL and Datavant partner to deliver advanced data and real-world evidence analytics to enhance drug development and commercialization
Sep 11,2018: TOPC : PAREXEL Advances Patient-Centric Drug Development with Introduction of Its Patient Innovation Center[Newswire : Healthcare-BW]
Sep 11,2018: PAREXEL advances patient-centric drug development with introduction of its patient innovation center
Reasons to Buy
- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 – About the Company 5
Parexel International Corp – Key Facts 5
Parexel International Corp – Key Employees 6
Parexel International Corp – Key Employee Biographies 8
Parexel International Corp – Major Products and Services 10
Parexel International Corp – History 12
Parexel International Corp – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Section 2 – Company Analysis 22
Company Overview 22
Parexel International Corp – Business Description 23
Parexel International Corp – SWOT Analysis 24
SWOT Analysis – Overview 24
Parexel International Corp – Strengths 24
Parexel International Corp – Weaknesses 25
Parexel International Corp – Opportunities 26
Parexel International Corp – Threats 27
Parexel International Corp – Key Competitors 28
Section 3 – Company’s Lifesciences Financial Deals and Alliances 29
Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 29
Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 30
Parexel International Corp, Recent Deals Summary 31
Section 4 – Company’s Recent Developments 32
Oct 09, 2018: PAREXEL announces several new patient-centric innovations to address drug development challenges 32
Sep 17, 2018: PAREXEL and Datavant partner to deliver advanced data and Real-World Evidence Analytics to enhance drug development and commercialization 33
Sep 11, 2018: PAREXEL advances patient-centric drug development with introduction of its patient innovation center 34
Sep 11, 2018: TOPC : PAREXEL Advances Patient-Centric Drug Development with Introduction of Its Patient Innovation Center[Newswire : Healthcare-BW] 35
Sep 11, 2018: TOPC : PAREXEL Advances Patient-Centric Drug Development with Introduction of Its Patient Innovation Center[Newswire : Healthcare-BW] 38
Sep 11, 2018: TOPC : PAREXEL Advances Patient-Centric Drug Development with Introduction of Its Patient Innovation Center[Newswire : Healthcare-BW] 41
Aug 16, 2018: PAREXEL announces appointment of two key executives 44
Jun 25, 2018: New Research Reveals Drug Development Innovations Positively Impact Clinical Trial Timelines, Likelihood of Market Launch and Patient Access, Yet Are Not Widely Adopted 45
Jun 18, 2018: PAREXEL to Lead Discussions on Global Drug Development Unveil New Industry Research at DIA Annual Meeting 46
May 30, 2018: PAREXEL Receives Multiple Industry Recognitions for its Service to the Life Sciences Industry 47
Section 5 – Appendix 48
Methodology 48
About GlobalData 48
Contact Us 48
Disclaimer 48
List of Tables
Parexel International Corp, Key Facts 5
Parexel International Corp, Key Employees 6
Parexel International Corp, Key Employee Biographies 8
Parexel International Corp, Major Products and Services 10
Parexel International Corp, History 12
Parexel International Corp, Other Locations 17
Parexel International Corp, Subsidiaries 18
Parexel International Corp, Key Competitors 28
Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 29
Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 30
Parexel International Corp, Recent Deals Summary 31
List of Figures
Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 29
Parexel International Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 30